Speaker illustration

Doctor Seng Chan You

Yonsei University, Seoul (Korea (Republic of))

Comparison between first line dual-combination therapies in hypertension: nationwide population based cohort study

Event: ESC Congress 2017

Topic: Treatment of hypertension

Session: Strategies to improve the treatment of hypertension

Thumbnail

Rate-control treatment and clinical outcomes in patients with atrial fibrillation and obstructive lung disease

Event: ESC Congress 2017

Topic: Atrial fibrillation (AF)

Session: Drug treatment

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb